Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine November 2011, 52 (11) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 52 no. 11 11A-12A

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 1, 2011.

Copyright & Usage 
© 2011 by Society of Nuclear Medicine

Author Information

Statistics from Altmetric.com

Cited By...

  • 567 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2011 to April 2025

AbstractFullPdf
Nov 2011086102
Dec 20110915
Jan 2012028
Feb 2012061
Mar 2012021
Apr 2012023
May 20120106
Jun 2012097
Jul 2012089
Aug 2012067
Sep 2012094
Oct 20120157
Nov 20120252
Dec 20120143
Jan 20130131
Feb 20130307
Mar 20130811
Apr 201301113
May 20130229
Jun 20130343
Jul 2013031
Aug 20130143
Sep 2013022
Oct 2013033
Nov 2013020
Dec 2013002
Jan 2014032
Feb 20140812
Mar 2014035
Apr 2014052
May 2014051
Jun 2014031
Jul 2014053
Aug 2014040
Sep 20140102
Oct 20140135
Nov 2014044
Dec 2014052
Jan 2015008
Feb 2015072
Mar 2015080
Apr 2015062
May 2015068
Jun 2015080
Jul 2015034
Aug 2015010
Sep 2015091
Oct 20150971
Nov 2015037
Dec 2015077
Jan 2016043
Feb 2016012
Mar 2016025
Apr 2016040
May 2016001
Jun 2016070
Jul 2016022
Aug 2016010
Sep 2016010
Oct 2016036
Dec 2016020
Jan 2017040
Feb 2017050
Mar 2017023
Apr 2017022
May 2017010
Jun 2017041
Jul 2017032
Aug 2017021
Sep 2017031
Oct 2017022
Nov 2017021
Dec 2017031
Jan 2018023
Feb 2018011
Mar 2018010
Apr 2018012
May 2018001
Jul 2018040
Aug 2018010
Sep 2018020
Oct 2018040
Nov 2018070
Jan 2019010
Feb 2019031
Mar 2019011
Apr 2019010
May 2019010
Jun 2019010
Jul 2019020
Aug 2019020
Sep 2019040
Oct 2019022
Nov 2019012
Dec 2019021
Jan 2020021
Mar 2020023
Apr 2020022
May 2020003
Jun 2020043
Jul 2020010
Aug 2020031
Sep 2020010
Oct 2020010
Nov 2020031
Dec 2020010
Jan 2021031
Feb 2021079
Mar 2021031
Apr 2021040
May 2021021
Jun 2021011
Jul 2021029
Aug 2021020
Sep 2021010
Oct 2021012
Nov 2021010
Dec 2021042
Jan 2022021
Feb 2022041
Mar 2022044
Apr 2022002
May 2022031
Jun 2022050
Jul 20220443
Aug 2022050
Sep 2022020
Oct 2022010
Nov 2022020
Dec 2022060
Jan 20230110
Feb 2023070
Mar 2023065
Apr 20230140
May 2023063
Jun 2023010
Jul 20230110
Aug 2023013
Sep 2023021
Oct 2023001
Nov 2023062
Dec 2023046
Jan 2024070
Feb 2024022
Mar 2024021
Apr 20240123
May 2024030
Jun 20240113
Jul 20240404
Aug 20240326
Sep 2024012
Oct 20240123
Nov 2024011
Dec 2024060
Jan 2025010
Feb 2025051
Mar 2025042
Apr 2025059
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (11)
Journal of Nuclear Medicine
Vol. 52, Issue 11
November 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Nov 2011, 52 (11) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Nov 2011, 52 (11) 11A-12A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia
  • 18F-FDG Uptake Rate Is a Biomarker of Eosinophilic Inflammation and Airway Response in Asthma
  • 64Cu-Labeled Peptide for PET of Breast Carcinomas Expressing the Thomsen-Friedenreich Carbohydrate Antigen
  • The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods
  • Looking Through the Vascular Normalization Window: Timing Antiangiogenic Treatment and Chemotherapy with 99mTc-Annexin A5
  • Micro-CT for Anatomic Referencing in PET and SPECT: Radiation Dose, Biologic Damage, and Image Quality
  • PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
  • Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
  • 18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
  • Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation
  • National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner
  • Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
  • CXCR4-Based Imaging Agents
  • Structural Abnormalities of the Coronary Arterial Wall—in Addition to Luminal Narrowing—Affect Myocardial Blood Flow Reserve
  • Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation
  • 99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab
  • Treatment with Octreotide Does Not Reduce Tumor Uptake of 68Ga-DOTATATE as Measured by PET/CT in Patients with Neuroendocrine Tumors
  • Multimodal Imaging with 18F-FDG PET and Cerenkov Luminescence Imaging After MLN4924 Treatment in a Human Lymphoma Xenograft Model
  • Practical Approach for Comparative Analysis of Multilesion Molecular Imaging Using a Semiautomated Program for PET/CT
  • Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET
  • Brain Amyloid Imaging
  • Comparison of 4 Radiolabeled Antagonists for Serotonin 5-HT7 Receptor Neuroimaging: Toward the First PET Radiotracer
  • Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma
  • Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non–Small Cell Lung Cancer Tumor Delineation
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire